Figueroa v. Secretary of Health & Human Services

101 Fed. Cl. 696, 2011 U.S. Claims LEXIS 2366, 2011 WL 6369773
CourtUnited States Court of Federal Claims
DecidedDecember 20, 2011
DocketNo. 10-750 V
StatusPublished
Cited by3 cases

This text of 101 Fed. Cl. 696 (Figueroa v. Secretary of Health & Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Figueroa v. Secretary of Health & Human Services, 101 Fed. Cl. 696, 2011 U.S. Claims LEXIS 2366, 2011 WL 6369773 (uscfc 2011).

Opinion

OPINION AND ORDER

BUSH, Judge.

Ms. Stephanie Vino Figueroa filed a petition for vaccine injury compensation on November 1, 2010. The alleged vaccine injury, however, was to Manny Figueroa, who died on April 16, 2010 of causes unrelated to his alleged vaccine injury. The petition was thus brought by Ms. Figueroa as personal representative of the estate of Manny Figueroa for an illness allegedly caused by a vaccine administered to Manny Figueroa. The special master assigned to this case ruled that Ms. Figueroa did not have standing to bring a petition for vaccine injury compensation in these circumstances. Fi[697]*697gueroa ex rel. Figueroa v. Sec’y of Health & Human Servs., No. 10-750V, 2011 WL 2784586 (Fed.Cl.Spec.Mstr. June 22, 2011). Petitioner now brings a motion for review of the special master’s decision dismissing her suit. This court affirms the decision of the special master for the reasons discussed below.

DISCUSSION

Ms. Figueroa seeks compensation under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-l to -34 (2006) (the Vaccine Act) for an illness Manny Figueroa suffered during the last two years of his life, although his death was caused by an unrelated cancer. Whether Ms. Figueroa may bring such a petition is a pure question of law. Because the Vaccine Act must be interpreted to answer this question, the court reviews the special master’s decision de novo. Zatuchni v. Sec’y of Health & Human Servs., 516 F.3d 1312, 1315 (Fed.Cir.2008) (citing 42 U.S.C. § 300aa-12(e)(2)(B) and Markovich v. Sec’y of Health & Human Servs., 477 F.3d 1353, 1355-56 (Fed.Cir.2007)).

The Vaccine Act permits petitions for vaccine injury compensation to be brought by three categories of persons, and states in relevant part that

any person who has sustained a vaccine-related injury, the legal representative of such person if such person is a minor or is disabled, or the legal representative of any person who died as the result of the administration of a vaccine set forth in the Vaccine Injury Table may ... file a petition for compensation under the Program.

42 U.S.C. § 300aa-ll(b)(l)(A). As an initial matter, this court must refrain from a de novo interpretation of the statutory text if binding precedent has already provided an interpretation of this section of the Vaccine Act. See Crowley v. United States, 398 F.3d 1329, 1335 (Fed.Cir.2005) (rejecting this court’s de novo interpretation of a statute when precedent provided a binding interpretation of the text). The precedential decision most on point which discusses standing to bring petitions under the Vaccine Act is Za-tuchni.

There is limited guidance in Zatuchni for the question presented by Ms. Figueroa’s petition, because the United States Court of Appeals for the Federal Circuit explicitly disavowed deciding this issue of standing:

We need not decide whether § 300aa-11(b)(1)(A) would permit the estate of a person who suffered vaccine-related injuries but died of a non-vaccine-related cause to file a petition for vaccine-related injury compensation, and thus express no view on that point____

Zatuchni, 516 F.3d at 1320-21. Nonetheless, there are at least three statements in Za-tuchni that bear consideration by this court. First, the panel majority indicated that the statutory text of § 300aa-ll(b)(l)(A) reflected a legislative intent to define the boundaries of Vaccine Act litigation according to certain policy choices. See id. at 1321 n. 10 (noting that “ § 300aa-ll(b)(l)(A) is simply one of several trade-offs and limitations in the Program, and we express no view on the policy choices reflected in those provisions”). Second, the panel majority noted that there was an apparent conflict between § 300aa-ll(b)(l)(A) and state law or federal common law principles which might permit a tort injury claim to survive the death of the tort victim. See id. (“By contrast, it may be noted that the federal common law approach offered by the dissent appears to conflict directly with § 300aa-ll(b)(l)(A). The dissent’s approach would allow a vaccine-related injury claim to survive in all cases — regardless of the cause of death or whether a petition was filed before or after death — and thus would permit a new petition for vaccine-related injury compensation to be filed by the estate of a person who did not die from a vaccine-related cause.”). Third, the Federal Circuit stated that the plain language of the Vaccine Act should be followed where it limits access to the remedies available under the Act in this court. See id. (“Where compensation is not available under the Program, or is seen by the claimant as unsatisfactory for any reason, however, the Act expressly contemplates that claimants will seek state-law remedies. Thus, faced with a scenario in which compensation is not available under the Program, the appropriate response is not [698]*698to expand the scope of the Act in order to ‘harmonize’ the Act with state law, but rather to follow the unambiguous language of the Act and allow the claimant to proceed to state court.”).

There may be some question as to whether these statements in Zatuchni were necessary to the resolution of that case, or were dicta. Even if these statements could be considered to be mere dicta, the court believes that weight should nonetheless be given the panel’s interpretation of § 300aa-11(b)(1)(A) and other limitations set forth in the Vaccine Act. See Ariad Pharm., Inc. v. Eli Lilly & Co., 598 F.3d 1336, 1347 (Fed.Cir.2010) (“As a subordinate federal court, we may not so easily dismiss such statements as dicta but are bound to follow them.” (citing Stone Container Corp. v. United States, 229 F.3d 1345, 1349-50 (Fed.Cir.2000))). Thus, following Zatuchni, this court holds that the three categories of petitioners described in § 300aa-ll(b)(l)(A) reflect policy choices enshrined in the Act, that this section trumps other laws that might otherwise permit someone to file a Vaccine Act petition, and that this court should not try to expand the scope of the three categories of petitioners set forth in the text of § 300aa-ll(b)(l)(A).2

The court turns to the standing issue presented by this case and the three categories of petitioners set forth in § 300aa-11(b)(1)(A). Clearly Ms. Figueroa is not the allegedly injured vaecinee, as required for category one, and Manny Figueroa was neither a minor nor disabled when the petition was filed, as required for category two. Furthermore, Manny Figueroa did not die of his alleged vaccine injury.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
101 Fed. Cl. 696, 2011 U.S. Claims LEXIS 2366, 2011 WL 6369773, Counsel Stack Legal Research, https://law.counselstack.com/opinion/figueroa-v-secretary-of-health-human-services-uscfc-2011.